← Eichor
Condition: Mtd Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mtd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Momelotinib During and After HCT in Myelofibrosis
Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT07104799A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Stud
Phase 1 · 1 location(s) · Medigen Biotechnology Corporation · NCT05394714Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Phase 1 · 10 location(s) · SciTech Development, Inc. · NCT04234048IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · 13 location(s) · Iksuda Therapeutics Ltd. · NCT05365659Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
Phase 1/Phase 2 · 32 location(s) · Fondazione Italiana Linfomi - ETS · NCT05300282Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06487481Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
NA · 1 location(s) · Emory University · NCT07176988IKS014 in Advanced Solid Tumors That Express HER2
Phase 1 · 13 location(s) · Iksuda Therapeutics Ltd. · NCT05872295Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractor
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT02390752Losartan + Sunitinib in Treatment of Osteosarcoma
Phase 1 · 4 location(s) · University of Colorado, Denver · NCT03900793A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT06882746A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors
Phase 1/Phase 2 · 1 location(s) · SUNHO（China）BioPharmaceutical CO., Ltd. · NCT06292208Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
Phase 1/Phase 2 · 3 location(s) · Plus Therapeutics · NCT01906385Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Phase 1/Phase 2 · 4 location(s) · City of Hope Medical Center · NCT03523975This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · 16 location(s) · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451SB17170 Phase 1 Clinical Trial in Solid Tumors
Phase 1 · 3 location(s) · SPARK Biopharma · NCT05522868A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and
Phase 1 · 9 location(s) · Boehringer Ingelheim · NCT07607678A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorect
Phase 1/Phase 2 · 1 location(s) · BeyondBio Inc. · NCT05093907This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and
Phase 1 · 8 location(s) · ABL Bio, Inc. · NCT04762641A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progre
Phase 1 · 1 location(s) · BeyondBio Inc. · NCT05769660Actinium Therapy for Late-stage Aggressive Sarcomas
Phase 1 · 6 location(s) · Ratio Therapeutics, Inc. · NCT07156565Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · BeyondBio Inc. · NCT03579836Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerate
Phase 1/Phase 2 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07708714A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tu
Phase 1/Phase 2 · 5 location(s) · Zhuhai Yufan Biotechnologies Co., Ltd · NCT05315167ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Phase 1 · 9 location(s) · Adcytherix SAS · NCT07238075A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric A
Phase 1 · 1 location(s) · Technische Universität Dresden · NCT05836896
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.